These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16949796)

  • 1. Subjective and behavioural consequences of striatal dopamine depletion in schizophrenia--findings from an in vivo SPECT study.
    Voruganti LN; Awad AG
    Schizophr Res; 2006 Dec; 88(1-3):179-86. PubMed ID: 16949796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective effects of AMPT-induced dopamine depletion in schizophrenia: correlation between dysphoric responses and striatal D(2) binding ratios on SPECT imaging.
    Voruganti L; Slomka P; Zabel P; Costa G; So A; Mattar A; Awad AG
    Neuropsychopharmacology; 2001 Nov; 25(5):642-50. PubMed ID: 11682247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures.
    Boot E; Booij J; Hasler G; Zinkstok JR; de Haan L; Linszen DH; van Amelsvoort TA
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1350-6. PubMed ID: 18283451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subjective experiences during dopamine depletion.
    de Haan L; Booij J; Lavalye J; van Amelsvoort T; Linszen D
    Am J Psychiatry; 2005 Sep; 162(9):1755. PubMed ID: 16135643
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine depletion and in vivo binding of PET D1 receptor radioligands: implications for imaging studies in schizophrenia.
    Guo N; Hwang DR; Lo ES; Huang YY; Laruelle M; Abi-Dargham A
    Neuropsychopharmacology; 2003 Sep; 28(9):1703-11. PubMed ID: 12813475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis.
    Bloemen OJ; de Koning MB; Gleich T; Meijer J; de Haan L; Linszen DH; Booij J; van Amelsvoort TA
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):126-32. PubMed ID: 22591910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic dysphoria: towards a new synthesis.
    Voruganti L; Awad AG
    Psychopharmacology (Berl); 2004 Jan; 171(2):121-32. PubMed ID: 14647964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study.
    da Silva Alves F; Bakker G; Schmitz N; Abeling N; Hasler G; van der Meer J; Nederveen A; de Haan L; Linszen D; van Amelsvoort T
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1577-86. PubMed ID: 23978392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia.
    Gevonden M; Booij J; van den Brink W; Heijtel D; van Os J; Selten JP
    JAMA Psychiatry; 2014 Dec; 71(12):1364-72. PubMed ID: 25271822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social support and striatal dopaminergic activities: is there a connection?
    Yeh TL; Lee IH; Chen PS; Yu L; Cheng SH; Yao WJ; Yang YK; Lu RB; Chiu NT
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1141-6. PubMed ID: 19540896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion.
    Zimmermann RC; Krahn LE; Klee GG; Ditkoff EC; Ory SJ; Sauer MV
    J Soc Gynecol Investig; 2001; 8(3):174-8. PubMed ID: 11390253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of L-dihydroxyphenylalanine on alertness and mood in alpha-methyl-para-tyrosine-treated healthy humans. Further evidence for the role of catecholamines in arousal and anxiety.
    McCann UD; Thorne D; Hall M; Popp K; Avery W; Sing H; Thomas M; Belenky G
    Neuropsychopharmacology; 1995 Aug; 13(1):41-52. PubMed ID: 8526970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
    Harrison MB; Kumar S; Hubbard CA; Trugman JM
    Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia.
    Ankenman R; Salvatore MF
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):65-9. PubMed ID: 17308229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-methyl-para-tyrosine (AMPT) in drug-free depressed patients.
    Miller HL; Delgado PL; Salomon RM; Heninger GR; Charney DS
    Neuropsychopharmacology; 1996 Mar; 14(3):151-7. PubMed ID: 8866698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone response to catecholamine depletion in unmedicated, remitted subjects with major depressive disorder and healthy controls.
    Homan P; Drevets WC; Hasler G
    J Clin Psychopharmacol; 2013 Oct; 33(5):621-6. PubMed ID: 23963054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in total plasma ghrelin levels following catecholamine depletion: relation to bulimic and depressive symptoms.
    Homan P; Grob S; Milos G; Schnyder U; Hasler G
    Psychoneuroendocrinology; 2013 Sep; 38(9):1545-52. PubMed ID: 23333252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging D2 receptor occupancy by endogenous dopamine in humans.
    Laruelle M; D'Souza CD; Baldwin RM; Abi-Dargham A; Kanes SJ; Fingado CL; Seibyl JP; Zoghbi SS; Bowers MB; Jatlow P; Charney DS; Innis RB
    Neuropsychopharmacology; 1997 Sep; 17(3):162-74. PubMed ID: 9272483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
    Leng A; Mura A; Hengerer B; Feldon J; Ferger B
    Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.